(Q47944438)

English

Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy

scientific article published in June 1998

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

prostate cancer

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

author name string

Ennis RD

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

Malyszko BK

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

Heitjan DF

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

O'Toole KM

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

Schiff PB

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

41

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

511-517

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

Prostate specific antigen following radiotherapy for local prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pelvic radiation therapy on serum levels of prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic classification as an alternative to anatomic staging for clinically localized prostate cancer: a proposal based on patients treated with external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Use of Prostate-Specific Antigen in Staging Patients With Newly Diagnosed Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen density: a new prognostic indicator for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(98)00104-7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

release_kjdbeihkhfdz7kt2zyof2efsqm

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9635696

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47944438&oldid=2176581243"